While the “national GLP-1 supply begins to stabilize,” the FDA notes that some other products – including dulaglutide ...
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback